Aims-To investigate the effects of Sadrenoceptor stimulation, using the agonist isoprenaline and the antagonist propranolol, on migrating motor complexes in the upper intestine of 16 healthy human volunteers. Methods-Fasting motility was monitored using a tube with water perfused side holes connected to a pneumohydraulic system. Continuous eight hour recordings were obtained from each volunteer after a 12 hour fasting period. In all experiments, saline was given as control for the first four hour period and ,-adrenergic agents for the next four hours. In separate control studies, saline was given for the whole eight hour period.
duced the number ofactivity fronts (phase III) of migrating motor complexes from 3 (2-4) in controls to 1 (0-2) during isoprenaline infusion (p<0.01). Also, phase II-like activity replaced the regular motility pattern (p<0.01). By contrast, propranolol (25 ,ug/kg/min) did not induce any significant changes in phase III compared with controls. Saline alone had no effect on motor activity. Conclusions-Isoprenaline inhibited activity fronts in the human proximal small intestine and induced a postprandial-like motility pattern, whereas propranolol did not affect motor patterns. Stimulation of 0-adrenoceptors is of importance in the control of motor activity of the human small intestine, especially under stressful conditions with high adrenergic activity. (Gut 1997; 40: 376-380) The influence of adrenergic compounds on motility of the small intestine has been described in several investigations on different species. Stimulation of (x2-adrenoceptors has been shown to inhibit intestinal motility in both animalsl" and humans,5 6 whereas cxl-adrenoceptors seem to be of minor importance in the control of gut motor activity. 7 However, P-adrenergic stimulation has also been shown to play a part in the regulation of fasting motility. In a recent study, we showed that 3-adrenoceptors regulate myoelectric activity in the small intestine of rats; stimulation of P2-adrenoceptors induces a postprandial-like motility pattern whereas stimulation of ,33-adrenoceptors inhibits myoelectric activity of the small intestine.8
In humans, f-adrenoceptor stimulation reduces oesophageal,9 antral,9 and duodenal motility.'0 By contrast, 3-adrenoceptor inhibition with propranolol was recently found to enhance motility of the oesophagus,"1 promote gastric emptying,12 increase colonic intraluminal pressure,13 and shorten the period of postoperative adynamic ileus after bowel surgery. '4 15 As an extension of our previous studies on effects of ,B-adrenergic compounds on myoelectric activity in rats,8 we evaluated the effects of isoprenaline and propranolol on fasting duodenojejunal motor activity in healthy volunteers. To our knowledge, no studies have yet been performed to investigate the effects of 3-adrenergic agents on the migrating motor complex in the small intestine ofhumans. Thus the purpose of this study was to explore the potential role of 3-adrenoceptors in the control of fasting motility in the human small bowel.
Methods

Volunteers
Sixteen healthy male volunteers aged 21-55 (mean 32 0) years participated in the study. None reported symptoms or history of gastrointestinal disease and none was on medication. Seven of the subjects also participated in a control study in which only saline was given. The experimental protocol was approved by the local ethics committee at the Karolinska Hospital. Informed consent was obtained from all subjects.
Intestinal motility recordings Motility of the proximal small intestine was monitored by means of a multichannel polyvinylchloride tube (William Cook, Bjaeverskov, Denmark). The tube was 250 cm in length and 4*7 mm in outer diameter and had seven channels 0-7 mm in width, ending as side holes at different levels. Four side holes, 10 cm apart, were used in this study. The tube assembly was passed through a nostril. Fluoroscopy was used to position the two proximal side holes in the descending (DI) and horizontal (D2) parts of the duodenum, and the distal two at the angle of Treitz (T) and in the jejunum (j). Each channel was continuously perfused with degassed water from a low compliance pneumohydraulic system (Arndorfer Medical Specialities, Greendale, WI, USA) at a rate of 0 4 ml/ min. The channels were connected to external pressure transducers (PDCR 75, Druck Ltd, Leicestershire, UK). Recordings were made on a multichannel ink jet recorder (Mingograph 81, Elema-Schonander, Stockholm, Sweden).
The velocity of the pressure rise on sudden occlusion of the recording system was 200 mm Hg/s in each channel.
Study design
The volunteers fasted overnight before the experiment. Recordings were started at 8 00-8 30 am and continued for eight hours. Volunteers were in recumbent position throughout the experiment. Each experiment consisted of two consecutive motility registration periods of four hours duration. A continuous infusion of saline was given during the first four hour control period and either saline, isoprenaline, or propranolol during the next four hours.
In the control group, comprising seven subjects, saline was given for two consecutive four hour periods. Isoprenaline (2-5 ,ug/kg/min) was given to nine subjects and propranolol (25 ,ug/kg/min) was given to seven volunteers. Blood pressure and heart rate were registered 10 minutes before drug administration and every 10 minutes thereafter. Subjects were monitored for side effects throughout the study.
Drugs
These were saline solution (9 mg/ml Natriumklorid, Kabi Vitrum, Stockholm, Sweden), isoprenaline (Apoteksbolaget, Umea, Sweden) and propranolol (Zeneca, Macclesfield, Cheshire, UK).
Data analysis of migrating motor complex Recordings were inspected by two independent observers who agreed on the presence or absence of motor patterns. Migrating motor complexes were identified according to criteria of Vantrappen et all6: (1) appearance of uninterrupted bursts of pressure waves with a frequency of 11-12 contractions per minute (phase III), (2) aboral migration of phase III activity passing at least the distal two registration points, and (3) a period of complete quiescence after phase III activity. Phase III of migrating motor complexes (activity front) was defined as the presence of uninterrupted phasic pressure changes for at least two minutes at the maximal frequency for that locus. The duration of phase III at each locus was measured from onset of regular contractions to quiescence. The propagation velocity of phase III was calculated by dividing the traversed distance from onset of phase III by the time interval from one registration point to the next. Phase II was defined as having > 1 phasic contractions per minute, whereas phase I was defined as silence.
Statistics
Results are expressed as median values and range. Statistical comparisons with controls were made with Wilcoxon's signed rank test; p<005 was considered significant.
Results
In every subject, each phase III of migrating motor complexes was observed migrating over all four intestinal recording sites.
In control studies with saline, the number of phase III migrating motor complexes recorded during the first four hour infusion period were 2 (2-4), compared with 2 (1-3) during the subsequent four hour recording period. Also, no changes were found for duration, contraction frequency, and propagation velocity of phase III between the two four hour periods. (1)5 6 7 Thollander, Svensson, Hellstrdm Characteristics ofphase III of the migrating motor complexes in human volunteers during a four hour infusion of saline, followed by a four hour infusion of either isoprenaline (2 5 ,ug/kg/min; n=9), or propranolol (25 ,ug/kg/min; n= 7) and propagation velocity of phase III of migrating motor complexes compared with controls (Table) .While suppressing the migrating motor complex pattern, isoprenaline induced phase II-like activity throughout the four hour infusion period. An increase in fraction of time occupied by this phase II-like activity was found (p<0 01), whereas decreases in phase I and III activity were registered (each p<0 01; Fig 2) . Isoprenaline increased systolic blood pressure from 120 
Effects of /3-adrenoceptor inhibition on migrating motor complex pattern
With propranolol at a dose of 25 Fg/kg/min, the frequency of phase III did not change significantly (2 (1-3) during the control period and 2 (1-4) during propranolol infusion; Fig 3) . No changes in duration, contraction frequency, or propagation velocity of phase III between the two four hour periods were found (Table) .
The time fraction of the different phases of migrating motor complexes during propranolol infusion did not show any significant differences compared with the control period except for phase I (p<0 05; Fig 2) .
Propranolol decreased systolic blood pressure from 120 (110-140) to 110 (100-130) mm Hg (p<0 05), whereas the diastolic pressure increased from 69 (55-80) to 80 (60-85) mm Hg (p<0 05). The heart rate decreased from 65 (60-79) during the control period to 51 (48-72) beats/min during propranolol infusion (p<0 05).
Discussion
Inhibitory sympathetic influence on gut motility was described as early as 1899 by Bayliss Finally, as the dose of isoprenaline used in our study is within recommendations for clinical usage, central nervous effects of the drug would be minimal. In this study, no major side effects were noted by the subjects when isoprenaline or propranolol was given. The findings, therefore, indicate that 3-adrenergic control of motor activity in human small intestine involves peripheral mechanisms. A possible clinical implication of these findings relates to the increasing use of pharmacological agents to ameloriate motility disorders of the gastrointestinal tract in humans. 
